You are here

Home / Our Progress / Where our funding goes / Institutions we've funded / University of California, Davis
  • Share
  • Print

University of California, Davis

Total Awards: 
36
Award Value: 
$129,532,900
Major Facility Name: 
Institute for Regenerative cures
Institution type: 
Not for profit

Awards to the Institution

Award Value
Tools and Technologies III: J. Leach Multi-modal technology for non-destructive characterization of bioengineered tissues $1,842,792
Tools and Technologies III: Laura Marcu Multimodal platform combining optical and ultrasonic technologies for in vivo nondestructive evaluation of engineered vascular tissue constructs $1,834,474
Shared Labs: Alice Tarantal Translational Human Embryonic Stem Cell Shared Research Facility $1,728,111
Basic Biology IV: Deborah Lieu Induction of Pluripotent Stem Cell-Derived Pacemaking Cells $1,333,800
Research Training II: Frederick Meyers Stem Cell Training Program $5,822,412
Early Translational III: Walter Boyd Extracellular Matrix Bioscaffold Augmented with Human Stem Cells for Cardiovascular Repair $4,633,149
Disease Team Therapy Development - Research: Vicki Wheelock MSC engineered to produce BDNF for the treatment of Huntington's disease $17,857,797
Disease Team Therapy Development - Research: John Laird Phase I study of IM Injection of VEGF-Producing MSC for the Treatment of Critical Limb Ischemia $12,113,602
Creativity Awards: Gerhard Bauer Internship at a Cutting Edge CIRM-funded Stem Cell Research Facility $299,928
Early Translational I: Alice Tarantal In Utero Model to Assess the Fate of Transplanted Human Cells for Translational Research and Pediatric Therapies $3,143,392
New Faculty Physician Scientist: Emanual Maverakis Tunable hydrogels for therapeutic delivery of multipotent stem cells. $2,772,000
Disease Team Therapy Development III: Peter Belafsky Tissue Engineered Recellularized Laryngotracheal Implants $4,439,921
Basic Biology I: Min Zhao Directing migration of human stem cells with electric fields $816,228
Major Facilities: Larry Vanderhoef UC Davis CIRM Institute $20,082,400
Tools and Technologies I: Kit Lam Discovery of adhesion ligands for pluripotent human stem cells $834,003
Disease Team Therapy Development - Research: Nancy Lane Treatment of osteoporosis with endogenous Mesenchymal stem cells $19,999,867
Comprehensive Grant: Mark Zern An in vitro and in vivo comparison among three different human hepatic stem cell populations $2,251,223
Disease Team Therapy Planning I: Nancy Lane Increasing the endogenous mesenchymal stem cells to the bone surface to treat osteoporosis $107,750
Basic Biology II: Eric Kurzrock Differentiation of Human Embryonic Stem Cells into Urothelium $849,037
Shared Labs: Alice Tarantal Translational Human Embryonic Stem Cell Shared Research Facility $2,000,000
Transplantation Immunology: William Murphy Donor natural killer (NK) cells as “veto” cells to promote donor-specific tolerance $1,257,601
Comprehensive Grant: Alice Tarantal Preclinical Model for Labeling, Transplant, and In Vivo Imaging of Differentiated Human Embryonic Stem Cells $2,166,757
Disease Team Therapy Planning I: Martin Birchall Airways for Children $19,800
Early Translational II: Mark Zern Liver Cell Transplantation $4,215,748
New Faculty I: Chong-Xian Pan Combinatorial Chemistry Approaches to Develop LIgands against Leukemia Stem Cells $2,386,409
Early Translational I: Jan Nolta Sustained siRNA production from human MSC to treat Huntingtons Disease and other neurodegenerative disorders $2,615,674
Training Grant I-1: Frederick Meyers Stem Cell Research Training Grant $1,780,859
Early Translational II: Roslyn Isseroff Bone Marrow Mesenchymal Stem Cells to Heal Chronic Diabetic Wounds $4,635,576
SEED Grant: Ebenezer Yamoah Hair Cells and Spiral Ganglion Neuron Differentiation from Human Embryonic Stem Cells $458,071
Disease Team Therapy Planning I: John Laird Phase I study of IM Injection of VEGF Producing MSC for the Treatment of Critical Limb Ischemia $76,066
Early Translational III: Kyriacos Athanasiou Tissue engineered cartilage from autologous, dermis-isolated, adult, stem (DIAS) cells $1,735,703
SEED Grant: A. Reddi hESCs for Articular Cartilage Regeneration $301,703
Disease Team Therapy Planning I: Vicki Wheelock MSC engineered to produce BDNF for the treatment of Huntington's disease $97,564
Tools and Technologies I: Alice Tarantal In Vivo Imaging for the Detection and Quantitation of Transplanted Stem/Progenitor Cells in Nonhuman Primates $799,350
New Faculty II: Paul Knoepfler Molecular mechanisms governing hESC and iPS cell self-renewal and pluripotency $2,157,255
Disease Team Therapy Planning I: Mehrdad Abedi RUNNING TITLE: Stem Cell Gene Therapy for HIV in AIDS Lymphoma Patients $66,880
Total:
$129,532,902.00
Icon for xls export

Follow Us


© 2013 California Institute for Regenerative Medicine